Skip to content
Disclosery

EXANE DERIVATIVES: PFE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on PFE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 13,531 PFE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 13,531 shares
    Change vs previous 13F -7,785 shares

    0.41% of the 13F portfolio, value $709,274.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 21,316 shares
    Change vs previous 13F -819 shares

    0.31% of the 13F portfolio, value $1,103,446.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 22,135 shares
    Change vs previous 13F +2,361 shares

    0.32% of the 13F portfolio, value $1,307,006.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 19,774 shares
    Change vs previous 13F -11,435 shares

    0.21% of the 13F portfolio, value $850,438.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 31,209 shares
    Change vs previous 13F -11,701 shares

    0.29% of the 13F portfolio, value $1,237,398.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 42,910 shares
    Change vs previous 13F +14,132 shares

    0.47% of the 13F portfolio, value $1,554,535.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 28,778 shares
    Change vs previous 13F +19,756 shares

    0.32% of the 13F portfolio, value $1,059,252.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 9,022 shares
    Change vs previous 13F not available

    0.11% of the 13F portfolio, value $331,094.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).